INTERVIEW: Collaboration Key For China Regulatory Reforms, RDPAC Says (Part 2)
This article was originally published in PharmAsia News
Executive Summary
The days when foreign investments were welcomed with open arms in China seem to be gone, and a toughening environment is setting in. As the head of the top multinational research-based pharma association in the country, RDPAC managing director Joseph Cho is looking to local partnerships to pursue regulatory reforms and expand new drug access in a rapidly changing market.